Bristol Myers Squibb Donates $11 Million to Advance Health Equity
February 24 2021 - 5:59AM
Business Wire
Delivering on commitments announced in 2020,
BMS donates funds to 56 nonprofits serving medically underserved
populations across the U.S.
Bristol Myers Squibb (NYSE: BMY) today announced it has donated
a total of $11 million to 56 nonprofit organizations focused on
advancing health equity in the United States. These organizations
will deliver programs to improve access to high-quality care as
well as increase disease awareness and education in racially and
ethnically diverse and medically underserved communities, and to
improve diversity in clinical research.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210224005284/en/
BMS Commitment To Advance Health Equity
(Graphic: Business Wire)
The donations, awarded in response to a special request for
proposals, leverage $11 million of the $150 million pledged by the
company in August 2020 to advance diversity, inclusion and health
equity.
“We are realizing our vision to transform patients’ lives
through science as we build upon our company’s strong foundation of
addressing global health disparities to become one of the world’s
most inclusive biopharma companies,” said Adam Lenkowsky, Senior
Vice President, General Manager of U.S. Commercial at Bristol Myers
Squibb. “We understand that the need has never been more urgent,
and we have made it a priority to focus our capabilities and
resources to eliminate the barriers to accessing high-quality care
that exist for underserved and vulnerable populations.”
He added, “In line with this priority, we have chosen
organizations that have demonstrated a track record of innovative
and effective work in health equity and strong ties to patients and
communities. Individually, each is directing its expertise to
address the root causes of inequities and to create sustainable
solutions. Collectively, this funding initiative will effect change
within the health care ecosystem to positively impact the equitable
delivery of quality healthcare.”
The grant recipients include U.S.-based patient advocacy and
community-based organizations, health equity coalitions, medical
societies, nonprofit healthcare institutions and others to fuel
their health equity initiatives that support diverse populations
including Black/African Americans, Latinx/Hispanic Americans,
Asians, American Indian/Alaska Natives, Women, LGBTQ+, people with
disabilities and more. The full list can be viewed above.
The donations will fund development and delivery of innovative
health equity programs in areas of high unmet need within
therapeutic areas such as Oncology, Hematology, Immunology and
Cardiovascular Disease. The organizations will track metrics,
including the number of individuals served, demographics about the
targeted population and others that demonstrate the positive impact
of the donation. Evaluation reports will be provided every six
months, and a final impact report issued at the program
conclusion.
Commitment to Health Equity by Bristol Myers Squibb and the
Bristol Myers Squibb Foundation
Recognizing the need to better serve and collaborate with an
increasingly diverse U.S. population and underserved communities
around the world, Bristol Myers Squibb and the Bristol Myers Squibb
Foundation are taking concrete steps to accelerate their respective
commitments to health equity and diversity and inclusion. Bristol
Myers Squibb commits to providing an additional $50 million in
health equity and disease awareness and education focused grants by
2025, increasing awareness of its patient support and affordability
program in communities of need, and spending $1 billion with
diverse suppliers by 2025. The Bristol Myers Squibb Foundation, an
independent nonprofit organization, commits to delivering a new
clinical trial career development program for 250 new clinical
investigators who are racially and ethnically diverse or who are
committed to serving diverse and medically underserved communities,
and to mentoring 250 racially and ethnically diverse medical school
students to build a career pipeline with the goal of increasing
diversity of participants in clinical research.
For more information on the Bristol Myers Squibb and Bristol
Myers Squibb Foundation commitments to health equity and diversity
and inclusion, visit BMS.com.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial_news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210224005284/en/
Bristol Myers Squibb Media:
media@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2024 to May 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From May 2023 to May 2024